The breathing apparatus diseased remedy medicine of the cat which designates the remedy mannered null natural die human

摘要

PURPOSE:To obtain a feline respiratory disease therapeutic agent exhibiting remarkable effects, even when administered through routes except veins, and capable of reducing the labor load of a person on the therapeutic duty and the economical load of an owner. CONSTITUTION:The characteristic of this feline respiratory organ disease therapeutic agent comprises containing as an active ingredient an interferon produced by a microorganismic or animal cell into which an HuIFN-related gene collected from cells originated from human has been introduced. The HuIFN can mainly be classified into three kind types consisting of HuIFN-alpha, HuIFN-beta and HuIFN-gamma on the basis of antigenicity. Only one kind type of the HuIFN may be used, or a combination of different kind types of the HuIFN may be used. Even when any HuIFN is used, it is desirable to use the HuIFN having as high specific activity as possible. When orally administered, a partially or wholly purified product having a specific activity of approximately 105 international units/mg of protein is desirable, and when parenterally administered, a purified product having a specific activity of approximately 107 international units/mg of protein is desirable.